Get started
RocketTickers

FDA Grants INSYS Therapeutics ‘Fast Track’ Designation

Long
RocketTickers  
NASDAQ:INSY   None
Beyond Technical Analysis
1
0
beyondta
INSY: INSYS Therapeutics, Inc.
2018-08-30 06:00:00
FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.